MedPath
NMPA Approval

Tirzepatide Injection

国药准字HJ20255005

April 29, 2025

国药准字HJ20240020

Drug Information

替尔泊肽注射液

穆峰达

注射剂

按C₂₂₅H₃₄₈N₄₈O₆₈计,2.4ml∶30mg(每支多剂量注射器含4剂0.6ml:7.5mg)

化学药品

April 29, 2025

May 14, 2029

Company Information

Applicant Company

Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands

Manufacturing Company

eli lilly italia s.p.a.

V. Gramsci 731-733 50019 Sesto Fiorentino (FI) Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

替尔泊肽注射液 - NMPA 批准文号 | MedPath